Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.58
Bid: 16.58
Ask: 16.78
Change: 0.34 (2.09%)
Spread: 0.20 (1.206%)
Open: 17.00
High: 17.00
Low: 16.30
Prev. Close: 16.24
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Aug 2022 12:33

RNS Number : 4761U
EnQuest PLC
01 August 2022
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. Amjad Bseisu

2. The Amjad & Suha Bseisu Foundation

 

2

 

Reason for the notification

 

a)

 

Position/status

 

1. Chief Executive of EnQuest PLC

2. The Amjad & Suha Bseisu Foundation is a registered charity, of which Amjad Bseisu (CEO of EnQuest PLC) is a Trustee.

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

EnQuest PLC

b)

 

LEI

 

2138008LJU6WFQWOXJ73

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

£0.05 ordinary shares

Identification code

GB00B635TG28

b)

 

Nature of the transaction

 

 

1. Amjad Bseisu's EnQuest Nil Cost Share Options granted under the 2018 and 2019 EnQuest Performance Share Plans are being exercised.

2. The shares are being transferred directly into the Amjad & Suha Bseisu Foundation.

 

On completion of the exercise and transfer process, Amjad Bseisu will have the ability to influence voting in respect of the following shareholdings in EnQuest PLC:

 

· The shareholding of Double A Limited, a company beneficially owned by the extended family of Amjad Bseisu - 10.48% (197,659,025 shares)

· The shareholding of The Amjad & Suha Bseisu Foundation, a registered charity, of which Amjad Bseisu (CEO of EnQuest PLC) is a Trustee - 1.72% (32,504,731 shares)

· The shareholding of Amjad Bseisu - 0.009% (176,959 shares).

 

c)

 

Price(s) and volume(s)

Price

Volume(s)

1.

£n/a

4,604,010

2.

£n/a

4,604,010

d)

Aggregated information

 

- Aggregated volume

- Price

 

n/a

 

e)

 

Date of the transactions

 

29 July 2022

 

f)

 

Place of the transactions

 

n/a

 

Ends

For further information please contact:

EnQuest PLC Tel: +44 (0)20 7925 4900

Kate Christ

Acting Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGGRMMMGZZM
Date   Source Headline
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company
24th Feb 20223:00 pmRNSHolding(s) in Company
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company
15th Feb 20223:00 pmRNSHolding(s) in Company
11th Feb 202210:00 amRNSDirector/PDMR Shareholding
3rd Feb 20227:00 amRNSOperations update
7th Jan 20229:32 amRNSDirector/PDMR Shareholding
22nd Dec 20218:36 amRNSDirectorate Change
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.